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Objectives. To evaluate the feasibility, technical
effectiveness and limb salvage potential of percuta-
neous transluminal angioplasty (PTA)1 , particularly
infrapopliteal, in diabetic subjects with ischaemic
foot ulcer.
Design. Intervention study with PTA in consecu-
tive series.
Setting. Six Diabetology Foot Centres and one Car-
diovascular Catheterization Laboratory in Italy.
Subjects. Two hundred and twenty-one consecutive
diabetic subjects hospitalized for ischaemic foot ulcer.
Interventions. Peripheral arterial occlusive disease
(PAOD) was investigated by means of foot pulses
assessment, ankle-brachial-index (ABI), transcuta-
neous oxygen tension (TcPO2) and duplex scanning.
If non-invasive parameters suggested PAOD, angi-
ography was performed and a PTA was carried out
during the same session.
Main outcome measures. PTA feasibility, improve-
ment of ABI and TcPO2, limb salvage rate, clinical
recurrence.
Results. On angiography, two patients had stenoses
which were <50% of the vessel diameter. PTA was
performed in 191 (85.3%) of the 219 subjects with
stenoses >50%, even when longer than 10 cm and/
or multiple/calcified. In 11 patients (5.8%) PTA was
performed in the proximal axis exclusively, in 81
(42.4%) patients in the infrapopliteal axis exclu-
sively and in 99 (51.8%) in both the femoropopliteal
and infrapopliteal axis. Both ABI and TcPO2
improved significantly after PTA (P < 0.0001).
Clinical recurrence occurred in 14 subjects: 10 of
whom underwent a second successful PTA. Of the
191 patients who underwent PTA, 10 (5.2%)
underwent an above-the-ankle amputation.
Conclusions. PTA, including infrapopliteal, is feas-
ible in most diabetic subjects with ischaemic foot
Journal of Internal Medicine 2002; 252: 225–232
ª 2002 Blackwell Science Ltd 225
ulcer and is effective for foot revascularization.
Clinical recurrence was infrequent and the proce-
dure could successfully be repeated in most cases. In
subjects treated successfully with PTA the above-
the-ankle amputation rate was low. PTA should be
considered as the revascularization treatment of first
choice in all diabetic subjects with foot ulcer and
PAOD.
Keywords: diabetic foot ulcer, infrapopliteal angi-
oplasty, major amputation, minor amputation, per-
ipheral arterial occlusive disease.
Introduction
In diabetic subjects with ischaemic foot ulcer,
successful revascularization reduces the rate of
major amputation [1]. Whilst the effectiveness of
peripheral by-pass, including distal by-pass, has
been established, the role of percutaneous translu-
minal angioplasty (PTA) and especially the feasibil-
ity and effectiveness of infrapopliteal angioplasty
remains to be elucidated [2]. Some reports indicate
that the effectiveness and outcome of limb salvage is
less favourable in diabetic compared with non-
diabetic subjects [3], whilst others report no differ-
ences in outcome [4]. Recent reviews on diabetic
foot care suggest that PTA should only be used for
proximal arteries [5] and is seldom considered
feasible [6].
Since July 1998, six diabetic foot centres employed
non-invasive tests to assess peripheral arterial occlu-
sive disease (PAOD) in all diabetic patients hospit-
alized for foot ulcer. All cases with non-invasive
parameters suggestive of PAOD were referred to a
specialized centre to be assessed angiographically
and undergo PTA in the same session when possible.
We sought to evaluate PTA feasibility, especially
infrapopliteal, foot revascularization effectiveness,
complications, clinical recurrence and limb salvage
rate in a population of consecutive diabetic patients
hospitalized for ischaemic foot ulcer.
Materials and methods
Patient selection
All diabetic subjects hospitalized at our foot centres
were evaluated for posterior tibial and dorsalis
pedal pulses, ankle-brachial index ratio (ABI) by
Doppler continuous wave technique, and transcu-
taneous oxygen tension (TcPO2) tested on the
dorsum of the foot. Duplex scanning was per-
formed in cases with either reduced or absent foot
pulses, ABI < 1 (in the absence of arterial
calcification), or TcPO2 < 50 mmHg (in the
absence of oedema). If at least two of these four
exams were abnormal, arteriography was carried
out and PTA revascularization performed concom-
itantly. In patients in which PTA was attempted
unsuccessfully a by-pass operation was considered
depending on the severity of obstructive disease
and surgical risk factor. Our diagnostic and thera-
peutic protocol for ischaemic diabetic foot ulcer is
show in Table 1.
PTA procedure
PTA was considered indicative for angiographically
documented obstructions greater than 50% of the
vessel lumen [7]. PTA revascularization technique
was employed extensively: no stenosis or occlusion
1. Non-invasive evaluation of PAOD:
• Tibial posterior and pedal pulse examination
• Determination of Ankle-Brachial Index (ABI) measured with Doppler continuous wave technique
• Determination of transcutaneous oxygen tension (TcPO2)measured at the dorsum of the foot
If one pulse is absent or diminished or TcPO2 < 50 mmHg or ABI < 1
duplex scanning: if stenoses >50% of veseel lumen
1. Angiography and concomitant PTA
2. PTA not feasible  By-pass if possible
3. Infrapopliteal PTA after femoropopliteal by-pass if indicated
4. Surgical therapy if necessary
Table 1 Diagnostic and
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was considered unsuitable a priori for PTA reca-
nalization. Stenoses and occlusions greater than
10 cm in length, consecutive multiple stenoses,
calcified occlusions, were treated by PTA. Vessel
recanalization was considered complete when direct
flow was obtained, with no significant residual
stenosis along the artery (Fig. 1).
All procedures were performed under local
anaesthesia through antegrade puncture of the
ipsilateral common femoral artery. A 6-French
vascular introducer was positioned to perform a
preliminary angiographic study. An angiographic
or percutaneous transluminal coronary angioplasty
(PTCA)2 0.014–0.035 in. guide wire was inserted to
pass through any arterial obstructions and a 3.0–
5.0 French balloon catheter, was used for the dila-
tation of 2–8 mm diameter arteries. The occur-
rence of thrombi was managed by catheter
aspiration and/or urokinase infusion. In 12 cases
self-expandable stents were inserted in 5–8 mm
diameter vessels. Stents were not placed in the
infrapopliteal arteries as the risk of thrombosis is
very high in such low-flow vessels. During the
procedure 3000–5000 IU of heparin was infused
intra-arterially. If spasm occurred, 0.1–0.2 mg of
nitroglycerin was infused as an intra-arterial in
bolus. All patients were prescribed ticlopidine
500 mg per day for 30 days and acetyl salicylic
acid 100 mg per day indefinitely.
Haemodynamic improvement
Both the ABI and TcPO2 values were reassessed
3–6 days after the PTA procedure.
Pain
Pain changes after PTA were recorded.
Recurrence
Recurrence was assessed on the basis of pain
reappearance, ulcer worsening or relapse. In these
situations, ABI and TcPO2 were reassessed [8]. If
those parameters were significantly worse (<15% of
the post-PTA value), a duplex scanning was per-
formed and, in case of a positive test, the patient
underwent another angiographic evaluation and, if
possible, another PTA procedure.
Complications
Haematomas at the puncture site were not consid-
ered a significant side-effect unless requiring surgery
or red cell transfusion. However, any event that
prolonged hospital stay during PTA or required
specific medical or surgical treatment immediately
after PTA were recorded as a major complication.
Limb salvage
We considered limb salvage successful when the
plantar stand was maintained, even when achieved
by tarsal-metatarsal amputation [9]. Any above-the-
ankle amputation was considered a failure.
Clinical events during follow-up
Patients were examined weekly after discharge and
until ulcer healing, and were examined every
2 months thereafter. All subjects were provided
with extra-deep rocker shoes with soft thermoform-
able leather and customized insoles.
Clinical recurrence, new ulceration, new major
amputation or reamputation, and ischaemic pain
recurrence were taken into account as events as well
as the time and cause of death.
Statistical methods
For the consecutive series of patients considered, a
descriptive statistics is reported as average values
and standard deviation for the continuous variables
and as percentages and contingency tables for the
qualitative and discrete variables. ABI and TcPO2
mean values before and after PTA were compared by
Student’s t-test. The 5% level has been assumed for
testing the null hypothesis and 95% level has been
taken for constructing the confidence intervals.
Results
Patient population
Between July 1998 and July 2000, 402 consecutive
diabetic subjects were hospitalized for foot ulcer, and
in 221 (55.0%) non-invasive vascular parameters
suggesting PAOD were detected. These 221 patients
were referred to a specialized centre for an angio-
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graphic study and, whenever possible, a concomit-
ant PTA procedure. Two patients had no angio-
graphic evidence of stenoses >50% of vessel
diameter: these two subjects were excluded from
the analysis, thus leaving a study population of 219
individuals. Stenoses >50% of vessel diameter were
located exclusively in the iliac/femoro/popliteal axis
in 11 patients, exclusively in the infrapopliteal axis
in 81 patients, and in both femoro-popliteal and
infrapopliteal axis in 127 patients.
Fig. 1 (a, b) Occlusion of the posterior tibial artery, multiple obstructions with obstruction longer than 10 cm of the anterior tibial
artery, occlusion of the pedal artery, critical stenosis of the peroneal artery. (c, d) Complete recanalization of peroneal and anterior tibial
arteries, pedal artery included.
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PTA feasibility
Percutaneous transluminal angioplasty was carried
out in 191 subjects (87.2%), in 28 (12.8%) it was not
feasible. The latter was because of complete calcified
occlusion of the ostium and because of the inability
to catheterize the proximal superficial femoral artery.
Eleven (5.8%) PTAs were performed exclusively in
the proximal axis, 81 (42.4%) exclusively in the
infrapopliteal arteries (42.4%), and 99 (51.8%) in
the femoropopliteal plus infrapopliteal arteries.
Table 2 shows the number of PTA procedures
performed in every artery of the lower limb with
foot ulcer, the mean length of the stenoses and the
occlusions recanalized, the percentage of the stenoses
or occlusions ‡10 cm in length recanalized.
The demographic and clinical characteristics of
the 191 subjects who underwent PTA are reported
in Table 3.
PTA technical effectiveness
Transcutaneous oxygen tension and ABI were
assessed both before and after PTA. TcPO2 was
measured in 180 patients: in 11 cases TcPO2 data
were lost. ABI was measured in 128 patients: in 62
patients it was impossible because of calcifications,
and in one case the data were lost. TcPO2 increased
from 21.3 ± 12.6 to 49.2 ± 16.8 mmHg, and ABI
from 0.53 ± 0.15 to 0.90 ± 0.18, both were highly
significant (P < 0.0001). Figure 2 shows the values
by class of TcPO2 and ABI before and after PTA.
PTA complications
No patients died during hospitalization for PTA. No
puncture site haematoma required blood transfusion
or surgery. A patient with ischaemic dilating cardi-
omyopathy had an acute renal failure which
resolved within 48 h of the procedure and was
managed medically. One subject complained of pain
at the puncture site for approximately a month after
PTA, with no documentable cause: abdominal
sonography and peripheral arterial duplex scanning
did not show any abnormality and pain resolved
spontaneously.
Recurrence
Clinical recurrence occurred in 14 patients (7.3%).
The average time to clinical recurrence was
4.6 months, range 1–12 months. In 10 patients
(71.4%), a second PTA was performed successfully.
Pain
In all patients successfully treated with PTA the pain
disappeared.
Outcome of foot lesion
Major amputation was carried out in 10 subjects
(5.2%), six above and four below the knee. Minor
amputation was carried out in 83 patients: 20
tarsal-metatarsals, 35 of one or more rays, 28 of one
or more toes. Ninety-eight patients healed with
debridement and local dressing.
Out of the 28 subjects in whom PTA was not
feasible, nine (32.1%) underwent surgical revascu-
larization. Of these nine subjects, one had a below-
the-knee amputation and one died in hospital
because of acute myocardial infarction. Of the 19
subjects considered by the vascular surgeon not to
be candidates for surgical reconstruction, six
Table 2 Recanalization with PTA performed in every artery of lower limb, mean length of the stenoses (50–99% lumen diameter loss) and
the occlusions (100% lumen loss) recanalized, percentage of stenoses and occlusions ‡10 cm of length recanalized
Stenoses Occlusions
Artery N Mean length (cm) Length ‡10 cm (N) N Mean length (cm) Length ‡10 cm (N)
Iliac trunk 9 4.8 ± 2.1 – – – –
Profunda femoral 4 3.3 ± 1.9 – 3 3 ± 1 –
Common/superificial femoral 58 8.7 ± 6.4 34.5% 41 11.3 ± 7.6 51.2%
Popliteal 23 7.7 ± 2.3 17.4% 16 6.4 ± 3.4 18.7%
Anterior tibial/pedal 33 6.3 ± 4.4 12.1% 42 10.6 ± 7.1 38.1%
Posterior tibial/plantar 18 5.7 ± 3.5 16.7% 17 11.5 ± 7.8 41.2%
Peroneal 42 7.6 ± 4.6 30.9% 26 6.9 ± 4.2 15.4%
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(31.6%) underwent a major amputation: five above
and one below the knee.
Follow-up
One hundred and ninety subjects were followed until
31 December 2000. Follow-up information was not
available for one patient after PTA and ulcer healing.
The mean follow-up was 14.1 ± 7.1 months, range
5–30 months, median 12 months. In 15 (7.9%)
patients a new ulceration occurred: in nine at the
original site and in six in another location. Ischae-
mic pain recurred in three subjects with worsening
of non-invasive vascular parameters. These patients
underwent a new arteriography that identified
obstructive lesions at different sites from those
originally treated. In these three patients a second
PTA was successfully performed. In the remaining
12 subjects non-invasive vascular parameters did
not vary and angiography was not deemed neces-
sary. All the ulcers healed with medical dressings.
No reamputation or new major amputations were
performed. Ten (5.3%) subjects died: seven due to
ischaemic cardiopathy, one due to stroke, one due to
pancreatic cancer, one due to geromarasmus. The
average time interval between PTA and death was
12 months.
Discussion
In our population PTA was used extensively. We
consider the term ‘extensive PTA’ to comprehend
the technical aim and the clinical method.
The technical aim is to achieve the maximum
available revascularization down to the foot inde-
pendently of the severity and diffusion of the
obstructive lesions. The majority of studies on PTA
in infrapopliteal vessels report the treatment of
isolated and short lesions, which are traditionally
considered the only successful application of percu-
taneous recanalization [10]. In our experience PTA
was even performed on very long stenoses or
occlusions, multiple lesions on the same vessel and
on calcified stenoses or occlusions.
Our clinical method considers every diabetic
subject with foot ulcer and stenosis >50% of vessel
Table 3 Demographic and clinical characteristics of the study population (N ¼ 191)
Men (N) 120 (62.8%)
Women (N) 71 (37.2%)
Age (years) 69.6 ± 9.4
Insulin therapy (N) 130 (68.1%)
Oral therapy (N) 61 (31.9%)
Diabetes duration (years) 19.6 ± 5.7
Retinopathy (fundus oculi by ophthalmologist) (N) 148 (77.5%)
Vibration perception threshold measured by biothesiometer >25 V (N) 98 (60.9%)
Insensitivity in >5/9 areas using Semmes–Weinstein monofilament 10 g (N) 96 (60.8%)
Achilles reflex absent (N) 97 (50.8%)
Renal impairment (creatinine value >133 lmol/L) (N) 91 (47.6%)
Dialysis (N) 7 (3.7%)
Antihypertensive therapy (N) 151 (79.1%)
Coronary artery disease (N) 106 (55.3%)
Body mass index (kg m)2) 26.4 ± 3.4







Pain (N) 126 (66.0%)
Infection (positive culture exam) (N) 155 (81.2%)
Arterial media calcifications (X-ray of the feet) (N) 81 (42.4%)
Tibial posterior and/or dorsalis pulse absent (N) 184 (96.3)
Ankle-Brachial Index measured with Doppler continuous wave technique (N ¼ 128) 0.53 ± 0.15
Transcutaneous oxygen tension measured at the dorsum of the foot (mmHg) (N ¼ 180) 21.3 ± 12.6
Data are N (%) or mean ± 1 SD.
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diameter in the peripheral arterial tree a candidate
for PTA revascularization, given the efficacy and low
risk of this procedure. In fact, general or spinal
anaesthesia is not necessary, there are no surgical
wounds, the side-effects are minimal and mortality is
very low [11, 12]. A failed PTA does not preclude a
subsequent by-pass operation.
For all these reasons we are currently considering
PTA as the procedure of first choice in diabetic
subjects with ischaemic foot ulcer, and we do not
limit the indication for PTA to those patients who
cannot undergo an operation [13]. Surgery is
considered a second-line procedure after PTA failure
[14].
The outcome of the foot lesion is the most relevant
issue when assessing the efficacy of any therapeutic
approach for ischaemic foot ulcer. Some authors
report very good clinical results of PTA in claudi-
cants, whilst in subjects with foot ulcer these are less
encouraging [15, 16]. As we have an efficient and
low-risk procedure in PTA, we do not consider it
correct, for ethical reasons, to randomize our
patients for surgical revascularization.
We believe that the above-the-ankle amputation
rate in the subjects who successfully underwent PTA
is very low in comparison to literature data [17] and
with our own historical data from the 1990s [18].
We believe that PTA revascularization has increased
the likelihood of successfully performing minor
amputations, which we consider as being limb-
salvage procedures in subjects with large loss of
tissue or gangrene who would otherwise most likely
have undergone a major amputation [19].
Our current strategy is to perform PTA procedures
in the same session as the angiographic evaluation.
This approach reduces both patient stress and the
amount of contrast administered, which are partic-
ularly relevant in subjects with cardiovascular
diseases or nephropathy.
Percutaneous transluminal angioplasty is thought
by some to be of limited efficacy because of its
supposedly high recurrence rate [7]. In our experi-
ence, however, the clinical recurrence rate has been
low. Especially, the recurrence was manageable by a
second PTA in many patients. The morphological
recurrence rate in our cases is probably higher than
the clinical recurrence rate. Nevertheless, when
tissue healing has occurred and no pain is present,
we consider a possible delayed closure of the
recanalysed vessel as clinically irrelevant. This is
similar to continued limb salvage which occurs after
closure of the surgical graft [20].
Our follow-up data of reamputation, new ampu-
tation, reulceration are encouraging. We would like
to emphasize the stress that our foot centres place on
counselling patients on foot care, correct use of
special shoes and insoles [21].
Our data demonstrates that PTA, including infra-
popliteal, is feasible in most diabetic subjects with
PAOD and foot ulcer and is effective for foot
revascularization. It is also feasible when very long,
multiple or calcified stenoses or occlusions are
present. Complications are rare if PTA is performed
by a skilled physician, and PTA can be performed
without any particular contraindications in patients
with cardiovascular disease, nephropathy or at high
surgical risk. Clinical recurrence rate is low and PTA
can be successfully repeated in most cases. In this
series, few patients required above-the-ankle ampu-
tation. All diabetic subjects with foot ulcer and
Fig. 2 TcPO2 (n ¼ 180) and ABI (n ¼ 128) values by class before
and after PTA procedure (n ¼ 191).
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PAOD should be considered as potential candidates
for revascularization with PTA.
Our experience is available ‘on line’ at the web
site: www.extrem-es-angioplasty.it.
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